Related references
Note: Only part of the references are listed.Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis
Xiang Hu et al.
ONCOLOGIST (2019)
De-escalated therapy for HR+/HER2+breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
V Guarneri et al.
ANNALS OF ONCOLOGY (2019)
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
Richard C. Turkington et al.
GUT (2019)
Stereotactic Radiation for Ultra-Central Lung Tumors: Good Idea, or Ultra-Risky?
David Palma et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer: Phase III KEYNOTE-)181 study.
Takashi Kojima et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
Shuang Qin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study
Osama Mohamad et al.
LANCET ONCOLOGY (2019)
Liquid biopsy and minimal residual disease - latest advances and implications for cure
Klaus Pantel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Treatment of multiple brain metastases using gadolinium nanoparticles and radiotherapy: NANO-RAD, a phase I study protocol
Camille Verry et al.
BMJ OPEN (2019)
CAR T-cells: costs, comparisons, and commentary
Annette E. Hay et al.
JOURNAL OF MEDICAL ECONOMICS (2019)
Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review
Rodolfo Chicas-Sett et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Is It Time for Safeguards in the Adoption of Robotic Surgery?
Kyle H. Sheetz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial
Andrea Bezjak et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
Tony S. K. Mok et al.
LANCET (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
Susanne Hofmann et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Brachytherapy: An overview for clinicians
Cyrus Chargari et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Quantitative evidence for early metastatic seeding in colorectal cancer
Zheng Hu et al.
NATURE GENETICS (2019)
The changing therapeutic landscape of head and neck cancer
John D. Cramer et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Focused very high-energy electron beams as a novel radiotherapy modality for producing high-dose volumetric elements
K. Kokurewicz et al.
SCIENTIFIC REPORTS (2019)
Phase II Study of Proton Beam Radiation Therapy for Patients With Breast Cancer Requiring Regional Nodal Irradiation
Rachel B. Jimenez et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In. Sarc): a multicentre, phase 2-3, randomised, controlled trial
Sylvie Bonvalot et al.
LANCET ONCOLOGY (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
Huseyin Naci et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
David J. Pinato et al.
JAMA ONCOLOGY (2019)
Prognostic Factors and Biomarkers of Responses to Immune Checkpoint Inhibitors in Lung Cancer
Andrea Bianco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus?Associated Oropharyngeal Squamous Cell Carcinoma
Bhishamjit S. Chera et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
Qian Chen et al.
ADVANCED MATERIALS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis
Katie L. Spencer et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2
Teresa Macarulla et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned
Lisa M. Lowenstein et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
The journey to CAR T cell therapy: the pediatric and young adult experience with relapsed or refractory B-ALL
George Hucks et al.
BLOOD CANCER JOURNAL (2019)
Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
Jonathan C. Dudley et al.
CANCER DISCOVERY (2019)
Low-cost thermophoretic profiling of extracellular-vesicle surface proteins for the early detection and classification of cancers
Chao Liu et al.
NATURE BIOMEDICAL ENGINEERING (2019)
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
Jony van Hilst et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam et al.
JAMA NETWORK OPEN (2019)
Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis
Richard S. Finn et al.
HEPATOLOGY (2018)
Improved survival in multiple myeloma, with a diminishing racial gap and a widening socioeconomic status gap over three decades
Tiantian Sun et al.
LEUKEMIA & LYMPHOMA (2018)
Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer T1a Renal Cancer
Adam D. Talenfeld et al.
ANNALS OF INTERNAL MEDICINE (2018)
Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation
Farnaz Najmi Varzaneh et al.
EUROPEAN RADIOLOGY (2018)
Review of Real-Time 3-Dimensional Image Guided Radiation Therapy on Standard-Equipped Cancer Radiation Therapy Systems: Are We at the Tipping Point for the Era of Real-Time Radiation Therapy?
Paul J. Keall et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial
Jose Thomas et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement
David C. Grossman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer
Remco J. Molenaar et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer
Hubert Y. Pan et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma
Caroline Robert et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors
Jingjing Zhang et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study
Geoffrey D. Coughlin et al.
LANCET ONCOLOGY (2018)
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
Wen-Zhao Zhong et al.
LANCET ONCOLOGY (2018)
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
A. Grothey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
Kulmira Nurgali et al.
FRONTIERS IN PHARMACOLOGY (2018)
Surgical injury: comparing open surgery and laparoscopy by markers of tissue damage
Jan Maca et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2018)
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
Jun Gong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine
Francois Lux et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
A comparison of relative survival and cause-specific survival methods to measure net survival in cancer populations
Nupur Makkar et al.
CANCER MEDICINE (2018)
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors A Systematic Review and Meta-analysis
Daniel Y. Wang et al.
JAMA ONCOLOGY (2018)
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
Pedro T. Ramirez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
Alexander Melamed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The fluctuating incidence, improved survival of patients with breast cancer, and disparities by age, race, and socioeconomic status by decade, 1981-2010
Guanming Lu et al.
CANCER MANAGEMENT AND RESEARCH (2018)
1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT
Denise Albano et al.
LUNG CANCER-TARGETS AND THERAPY (2018)
Hodgkin Lymphoma: A Review and Update on Recent Progress
Satish Shanbhag et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas
Sylvie Bonvalot et al.
CLINICAL CANCER RESEARCH (2017)
Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
Stephane Champiat et al.
CLINICAL CANCER RESEARCH (2017)
Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity
Rudolf A. Werner et al.
ONCOTARGET (2017)
The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer
Iain Murray et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results from a monoinstitutional cohort analysis of long-term survivors
Vitaliana De Sanctis et al.
HEMATOLOGICAL ONCOLOGY (2017)
National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer
Kristin A. Higgins et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
The Diagnosis and Treatment of Prostate Cancer A Review
Mark S. Litwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer A Randomized Clinical Trial
Alan P. Venook et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Postoperative Pelvic Radiotherapy in Patients With Endometrial Cancer May Increase the Risk for Secondary Pelvic Cancers: A Post Hoc Analysis of Results From the TME, PORTEC-1, and PORTEC-2 Trials
Michel D. Wissing et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Concurrent Chemotherapy and Radiation Therapy for Inoperable Locally Advanced Non-Small-Cell Lung Cancer
Kenneth E. Rosenzweig et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance
Bahare Zarrin et al.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2017)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Lesley Seymour et al.
LANCET ONCOLOGY (2017)
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui-hua Xu et al.
NATURE MATERIALS (2017)
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Hongchao Pan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer
T. S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Known, new and emerging risk factors of hepatocellular carcinoma
Dorra Trad et al.
PRESSE MEDICALE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Acute lymphoblastic leukemia: a comprehensive review and 2017 update
T. Terwilliger et al.
BLOOD CANCER JOURNAL (2017)
Improving radiotherapy in cancer treatment: Promises and challenges
Helen H. W. Chen et al.
ONCOTARGET (2017)
Micro-HCCs in rats with liver cirrhosis: paradoxical targeting effects with vascular disrupting agent CA4P
Yewei Liu et al.
ONCOTARGET (2017)
Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages
Shuncong Wang et al.
SCIENTIFIC REPORTS (2017)
Survival changes in Patients with Synovial Sarcoma, 1983-2012
Shuncong Wang et al.
JOURNAL OF CANCER (2017)
Defining a Hospital Volume Threshold for Minimally Invasive Pancreaticoduodenectomy in the United States
Mohamed Abdelgadir Adam et al.
JAMA SURGERY (2017)
Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Colon Cancer
Janna Manjelievskaia et al.
JAMA SURGERY (2017)
Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer
Jie Chen et al.
ACS NANO (2017)
Small-cell lung cancer: what we know, what we need to know and the path forward
Adi F. Gazdar et al.
NATURE REVIEWS CANCER (2017)
Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts
Jessica Hartmann et al.
EMBO MOLECULAR MEDICINE (2017)
Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine
Francoise Descotes et al.
BRITISH JOURNAL OF CANCER (2017)
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0, Tyr3] octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors
Tessa Brabander et al.
CLINICAL CANCER RESEARCH (2017)
Importance of Electric Fields from Ionized Nanoparticles for Radiation Therapy
M. L. Shmatov
PHYSICS OF PARTICLES AND NUCLEI LETTERS (2017)
The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy
Orit Kaidar-Person et al.
ANTI-CANCER DRUGS (2017)
Risk for Incomplete Resection after Macroscopic Radical Endoscopic Resection of T1 Colorectal Cancer: A Multicenter Cohort Study
Y. Backes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Long-term Recurrence-free Survival After Standard Endoscopic Resection Versus Surgical Resection of Submucosal Invasive Colorectal Cancer: A Population-based Study
Tim D. G. Belderbos et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Surgery for Cancer: A Trigger for Metastases
Samer Tohme et al.
CANCER RESEARCH (2017)
Radioactive Iodine Therapy of Differentiated Thyroid Carcinoma: Redesigning the Paradigm
Stanley J. Goldsmith
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY (2017)
Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration
Ka Wing Ma et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2017)
Proton therapy - Present and future
Radhe Mohan et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements
Sohyoung Her et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Comparison of survival rates in stage 1 renal cell carcinoma between partial nephrectomy and radical nephrectomy patients according to age distribution: a propensity score matching study
Toshio Takagi et al.
BJU INTERNATIONAL (2016)
Use of Radioactive Iodine for Thyroid Cancer and Risk for Second Primary Malignancy: A Nationwide Population-Based Study
Chung-Jen Teng et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Use of Radioactive Iodine for Thyroid Cancer and Risk for Second Primary Malignancy: A Nationwide Population-Based Study
Chung-Jen Teng et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Long-Term Outcome of Endoscopic Resection vs. Surgery for Early Gastric Cancer: A Non-inferiority-Matched Cohort Study
Jeung Hui Pyo et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement
Albert L. Siu et al.
ANNALS OF INTERNAL MEDICINE (2016)
Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study
Rebecca Landy et al.
BRITISH JOURNAL OF CANCER (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Mitotic catastrophe and cancer drug resistance: A link that must to be broken
Tatiana V. Denisenko et al.
DRUG RESISTANCE UPDATES (2016)
Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials
Johanna Ramroth et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies Modeling Study for the US Preventive Services Task Force
Amy B. Knudsen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study
Bradley J. Monk et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
Kazumasa Fujitani et al.
LANCET ONCOLOGY (2016)
Early dissemination seeds metastasis in breast cancer
Hedayatollah Hosseini et al.
NATURE (2016)
Mechanism of early dissemination and metastasis in Her2+ mammary cancer
Kathryn L. Harper et al.
NATURE (2016)
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness
H. Gilbert Welch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Radiotherapy for Non-Hodgkin's lymphoma: still standard practice and not an outdated treatment option
Michel Zimmermann et al.
RADIATION ONCOLOGY (2016)
Long term outcome and side effects in patients receiving low-dose l125 brachytherapy: a retrospective analysis
Pieter Logghe et al.
INTERNATIONAL BRAZ J UROL (2016)
Radioactive Iodine Administration Is Associated with Persistent Related Symptoms in Patients with Differentiated Thyroid Cancer
Pablo Florenzano et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2016)
Biliary tract perforation following percutaneous endobiliary radiofrequency ablation: A report of two cases
Chuanguo Zhou et al.
ONCOLOGY LETTERS (2016)
Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983-2012
Shuncong Wang et al.
ONCOTARGET (2016)
Gadolinium-Based Nanoparticles and Radiation Therapy for Multiple Brain Melanoma Metastases: Proof of Concept before Phase I Trial
Shady Kotb et al.
THERANOSTICS (2016)
Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis
Christopher J. D. Wallis et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Cancer drugs, survival, and ethics
Peter H. Wise
BMJ-BRITISH MEDICAL JOURNAL (2016)
Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis
Christopher J. D. Wallis et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Cancer drugs, survival, and ethics
Peter H. Wise
BMJ-BRITISH MEDICAL JOURNAL (2016)
Population-Based Colonoscopy Screening for Colorectal Cancer A Randomized Clinical Trial
Michael Bretthauer et al.
JAMA INTERNAL MEDICINE (2016)
A Review of Radiotherapy-Induced Late Effects Research after Advanced Technology Treatments
Wayne D. Newhauser et al.
FRONTIERS IN ONCOLOGY (2016)
Diagnosing cancer earlier: reviewing the evidence for improving cancer survival
S. C. Hiom
BRITISH JOURNAL OF CANCER (2015)
Anal Cancer: Current Standards in Care and Recent Changes in Practice
Ravi Shridhar et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts
Tracy E. Strecker et al.
CANCER LETTERS (2015)
Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab
Zeynep Eroglu et al.
EUROPEAN JOURNAL OF CANCER (2015)
Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study
Raffaella Marcheselli et al.
JOURNAL OF BREAST CANCER (2015)
Overall Response Rate, Progression-Free Survival, and Overall Survival With Targeted and Standard Therapies in Advanced Non-Small-Cell Lung Cancer: US Food and Drug Administration Trial-Level and Patient-Level Analyses
Gideon M. Blumenthal et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011
Ya-Chen Tina Shih et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Advances and Challenges in Treatment of Locally Advanced Rectal Cancer
J. Joshua Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Dirk Schadendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Transarterial chemoembolization: Modalities, indication, and patient selection
Wolfgang Sieghart et al.
JOURNAL OF HEPATOLOGY (2015)
Proteomic analysis to identify biomarkers in the primary tumour that predict response to neoadjuvant chemotherapy in liver metastases
Paul Sutton et al.
LANCET (2015)
Global cancer surgery: delivering safe, affordable, and timely cancer surgery
Richard Sullivan et al.
LANCET ONCOLOGY (2015)
Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors
Aadel A. Chaudhuri et al.
LUNG CANCER (2015)
Acute Lymphoblastic Leukemia in Children
Stephen P. Hunger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer
Theresa A. Lawrie et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future
Bryan A. Chan et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2015)
Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma
A. Horwich et al.
BRITISH JOURNAL OF CANCER (2014)
Costs of Radical Prostatectomy for Prostate Cancer: A Systematic Review
Christian Bolenz et al.
EUROPEAN UROLOGY (2014)
The Tumor Radiobiology of SRS and SBRT: Are More Than the 5 Rs Involved?
J. Martin Brown et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Chronic Lymphocytic Leukemia A Clinical Review
Chadi Nabhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Risk of Subsequent Malignant Neoplasms in Long-Term Hereditary Retinoblastoma Survivors After Chemotherapy and Radiotherapy
Jeannette R. Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial
John Primrose et al.
LANCET ONCOLOGY (2014)
Drug resistance to targeted therapies: Deja vu all over again
Floris H. Groenendijk et al.
MOLECULAR ONCOLOGY (2014)
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Benjamin J. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Testicular Cancer - Discoveries and Updates
Nasser H. Hanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Endoscopic resection as the first-line treatment for early colorectal cancer: comparison with surgery
Jun Heo et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2014)
Unintended Consequences of Expensive Cancer Therapeutics-The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity The John Conley Lecture
Tito Fojo et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2014)
Current Thyroid Cancer Trends in the United States
Louise Davies et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2014)
Radiation-induced small bowel disease: latest developments and clinical guidance
Rhodri Stacey et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2014)
Complications of radiofrequency ablation of hepatic tumors: Frequency and risk factors
Alexandre Zanchenko Fonseca et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Robot-assisted laparoscopic liver resection for hepatocellular carcinoma: short-term outcome
Eric C. H. Lai et al.
AMERICAN JOURNAL OF SURGERY (2013)
Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours
Saleem Jahangeer et al.
CANCER TREATMENT REVIEWS (2013)
Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
Shukui Qin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Laparoscopic Gastrectomy for Advanced Gastric Cancer: Are the Long-Term Results Comparable With Conventional Open Gastrectomy? A Systematic Review and Meta-Analysis
Yoon Young Choi et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis
Koji Oba et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Assessment of volumetric growth rates of small colorectal polyps with CT colonography: a longitudinal study of natural history
Perry J. Pickhardt et al.
LANCET ONCOLOGY (2013)
Fighting Prostate Cancer with Radium-223-Not Your Madame's Isotope
Neha Vapiwala et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review
Marion K. Mateos et al.
PEDIATRIC BLOOD & CANCER (2013)
Use of the Word Cure in Oncology
Kenneth Miller et al.
JOURNAL OF ONCOLOGY PRACTICE (2013)
Laparoscopy-Assisted Versus Open Distal Gastrectomy for Early Gastric Cancer Evidence from Randomized and Nonrandomized Clinical Trials
Yi-Ke Zeng et al.
ANNALS OF SURGERY (2012)
Mammography Screening and Risk of Breast Cancer Death: A Population-Based Case-Control Study
Suzie J. Otto et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives
Nicholas A. Saunders et al.
EMBO MOLECULAR MEDICINE (2012)
Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer
So Ri Kim et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
Kristin Bergethon et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Archie Bleyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The flexible sigmoidoscopie can save lives
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
Enhanced proton treatment in mouse tumors through proton irradiated nanoradiator effects on metallic nanoparticles
Jong-Ki Kim et al.
PHYSICS IN MEDICINE AND BIOLOGY (2012)
Chemoembolization for Hepatocellular Carcinoma
Riccardo Lencioni
SEMINARS IN ONCOLOGY (2012)
Treatment of locally advanced rectal cancer: Controversies and questions
Atthaphorn Trakarnsanga et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
Robert E. Schoen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ
Nicole Saenger et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Use of Radioactive Iodine for Thyroid Cancer
Megan R. Haymart et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Phase I/II Study of Pemetrexed With or Without ABT-751 in Advanced or Metastatic Non-Small-Cell Lung Cancer
Charles M. Rudin et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non-Small-Cell Lung Cancer
Primo N. Lara et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries
Amy Berrington de Gonzalez et al.
LANCET ONCOLOGY (2011)
Reduced Lung-Cancer Mortality with CT Screening
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Dual-targeting Anticancer Approach: Soil and Seed Principle
Junjie Li et al.
RADIOLOGY (2011)
Assessment of the Evolution of Cancer Treatment Therapies
Manuel Arruebo et al.
Cancers (2011)
Comparison of Second Cancer Risks from Brachytherapy and External Beam Therapy After Uterine Corpus Cancer
Stefan Loenn et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
The Learning Curve of Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium
Matthew H. Hayn et al.
EUROPEAN UROLOGY (2010)
RADIATION-ASSOCIATED KIDNEY INJURY
Laura A. Dawson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
RADIATION DOSE-VOLUME EFFECTS IN RADIATION-INDUCED RECTAL INJURY
Jeff M. Michalski et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation
Paul J. Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Overdiagnosis in Cancer
H. Gilbert Welch et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
Wendy S. Atkin et al.
LANCET (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Update on management of seminoma
Emma J. Alexander et al.
INDIAN JOURNAL OF UROLOGY (2010)
Screening for Breast Cancer: An Update for the US Preventive Services Task Force
Heidi D. Nelson et al.
ANNALS OF INTERNAL MEDICINE (2009)
Role of Chemotherapy in Hodgkin's Lymphoma
Pamela Seam et al.
CANCER JOURNAL (2009)
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
G. Kroemer et al.
CELL DEATH AND DIFFERENTIATION (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Intestinal Perforation in Colorectal Cancers Treated with Bevacizumab (Avastin®)
Young Il Choi et al.
Cancer Research and Treatment (2009)
A comparison of endoscopic treatment and surgery in early esophageal cancer: An analysis of surveillance epidemiology and end results data
Ananya Das et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Thromboembolic events with lenalidomide-based therapy for multiple myeloma
Smitha Patiyil Menon et al.
CANCER (2008)
From Single- to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage
S. Giordano et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Phase III Trial of Consolidation Therapy With Yttrium-90-Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma
Franck Morschhauser et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma
Ghil Suk Yoon et al.
JOURNAL OF UROLOGY (2008)
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Systemic chemotherapy for advanced non-small cell lung cancer: Recent advances and future directions
Suresh Ramalingam et al.
ONCOLOGIST (2008)
Endpoints for assessing drug activity in clinical trials
Richard Pazdur
ONCOLOGIST (2008)
Case selection in minimally invasive surgical treatment of neuroblastoma
John Boutros et al.
PEDIATRIC SURGERY INTERNATIONAL (2008)
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney
Edgar J. Rolleman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission
Jennifer R. Brown et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Normal tissue tolerance dose metrics for radiation therapy of major organs
Michael T. Milano et al.
SEMINARS IN RADIATION ONCOLOGY (2007)
Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen
Soonmyung Paik
ONCOLOGIST (2007)
A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors
Asa Palm et al.
ACTA ONCOLOGICA (2007)
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer
Robert Timmerman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Promoter methylation and response to chemotherapy and radiation in esophageal cancer
James P. Hamilton et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma
MS Chen et al.
ANNALS OF SURGERY (2006)
Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling
L Vincent et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Partial volume tolerance of the liver to radiation
LA Dawson et al.
SEMINARS IN RADIATION ONCOLOGY (2005)
The role of radiotherapy in cancer treatment - Estimating optimal utilization from a review of evidence-based clinical guidelines
G Delaney et al.
CANCER (2005)
Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures
G Apolone et al.
BRITISH JOURNAL OF CANCER (2005)
Skin biopsy rates and incidence of melanoma: population based ecological study
HG Welch et al.
BRITISH MEDICAL JOURNAL (2005)
A review of the general aspects of radiofrequency ablation
Y Ni et al.
ABDOMINAL IMAGING (2005)
The use of gold nanoparticles to enhance radiotherapy in mice
JF Hainfeld et al.
PHYSICS IN MEDICINE AND BIOLOGY (2004)
Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3] octreotate
JJM Teunissen et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies
G Morgan et al.
CLINICAL ONCOLOGY (2004)
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
DH Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer
J Bradley et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study - JCOG9204
N Ando et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review
SJ Otto et al.
LANCET (2003)
Complications of radiofrequency coagulation of liver tumours
S Mulier et al.
BRITISH JOURNAL OF SURGERY (2002)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Endoscopic perforation of the colon: Lessons from a 10-year study
ML Anderson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2000)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Apoptosis and cancer chemotherapy
G Makin et al.
CELL AND TISSUE RESEARCH (2000)
Share Paper
